Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04457076 · ClinicalTrials.gov registry record · Phase 3
Evaluation of the Efficacy, Safety, and Tolerability of LevoCept
A Phase 3 study, sponsored by Sebela Women's Health.
- Not yet
- Registry status
- Phase 3
- Development phase
- 1,525
- Enrollment target
NCT04457076 is a Phase 3 study that has not yet begun recruiting, run by Sebela Women's Health. The registered enrollment target is 1,525 participants.
The verdict
NCT04457076, a Phase 3 study, has not yet begun recruiting, sponsored by Sebela Women's Health.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 1,525 participants
- Enrollment target
Study Summary
To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept
Interventions
- DRUG LevoCept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,525 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2032-06-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04457076
The ClinicalTrials.gov registry entry for NCT04457076 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 1,525 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sebela Women's Health, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LevoCept is the first listed.
NCT04457076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04457076 about?
NCT04457076 is a clinical study titled "Evaluation of the Efficacy, Safety, and Tolerability of LevoCept". To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept
What is the current status of trial NCT04457076?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 1,525 participants. The study started on 2026-06-01. Estimated completion is 2032-06-01.
What interventions are being tested in trial NCT04457076?
The interventions under investigation include: LevoCept (DRUG).
Who is sponsoring clinical trial NCT04457076?
This trial is sponsored by Sebela Women's Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.